Skip to content

A Clinical trial to study the effect and Safety of Novel suture device S-FIX in patients undergoing Scleral fixated IOL surgery

To assess the safety and efficacy of Novel Cannulated Suture Thread Device for Easy Scleral Fixation of a Multipiece Intraocular Lens (S-FIX)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053566
Enrollment
30
Registered
2023-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H598- Other intraoperative and postprocedural complications and disorders of eye and adnexa, not elsewhere classified

Interventions

Intervention1: S FIX device: The S FIX device used for Intra ocular Haptic fixation in the sclera during Scleral fixated intraocular surgeries It is made of medical grade Stainless steel surgical nee

Sponsors

Aurolab
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) All patients with aphakia who require SFIOL implantation b) Both post cataract surgery and post trauma aphakia are included

Exclusion criteria

Exclusion criteria: a) History of glaucoma or uveitis b) Any other retinal pathology other than dislocated nucleus or intraocular lens c) Penetrating keratoplasty and any other combined procedures d) Monocular patients e) Pediatric age group less than 18 years of age f) Patients who are not willing to consent for the procedure

Design outcomes

Primary

MeasureTime frame
percentage of patients showing 1-2 lines of improvement in BCVA chi square testTimepoint: 45 days

Secondary

MeasureTime frame
-Intraoperative and post-operative complications-Percentage (Categorical) -IOL tilt assessment-percentage of eyes with tilt and mean IOL tilt in degree, continuous variable -Difference between pre-operative and POD 45 corneal endothelial cell count (wilcoxan signed rank test) Difference between mean pre-operative CMT and CMT at POD 45 (wilcoxan signed rank test)Timepoint: 45 days

Countries

India

Contacts

Public ContactDR Prabhu Baskaran

Aravind Eye Hospital

prabubaskaran@gmail.com914440956100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026